Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 5, 2014, Pages 1114-1119

  Trovo, Marco ^a   Minatel, Emilio ^a   Durofil, Elena ^a   Polesel, Jerry ^a   Avanzo, Michele ^a   Baresic, Tania ^a   Bearz, Alessandra ^a   Del Conte, Alessandro ^b   Franchin, Giovanni ^a   Gobitti, Carlo ^a   Rumeileh, Imad Abu ^a   Trovo, Mauro G ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Pordenone General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; DOSIMETRY; DRUG PRODUCTS; IRRADIATION; RADIATION; TOXICITY;

DOSIMETRIC PARAMETER; KAPLAN-MEIER ESTIMATES; KAPLAN-MEIER METHOD; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL RATES; RADIATION PNEUMONITIS; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

OXYGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISTANT METASTASIS; DOSIMETRY; FEMALE; FOLLOW UP; HEART VOLUME; HEMOPTYSIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MAXIMUM PERMISSIBLE DOSE; MULTILEAF COLLIMATOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXYGEN THERAPY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; RETREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; STEREOTACTIC BODY RADIATION THERAPY; TOMOTHERAPY; TREATMENT FAILURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIATION PNEUMONITIS; RADIOMETRY; RADIOSURGERY; REOPERATION; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84897911455     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.012     Document Type: Article

References (16)

1. W. Curran, C. Scott, and C. Langer et al. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 [abstract] Proc Am Soc Clin Oncol 22 2003 621a
2. C.A. Perez, K. Stanley, and P. Rubin et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group Cancer 45 1980 2744 2753
3. Bradley JD, Paulus R, Komaki R, et al. Randomized phase III comparison of standard dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiation therapy with or without cetuximab for stage IIIA/IIIB non-small-cell lung cancer: Preliminary findings on radiation dose in RTOG 0617. Available at: http://meetinglibrary.asco.org/content/110125-132. Accessed Month Day, Year.
4. D. Bradley, I. El Naqua, and R.E. Drzymala et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: The pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
5. J. Feddock, S.M. Arnold, and B.J. Shelton et al. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: A prospective study Int J Radiat Oncol Biol Phys 85 2013 1325 1331
6. Radiation Therapy Oncology Group. RTOG 0813 protocol information: Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. Available at: http://www.rtog.org/ClinicalTrials/ ProtocolTable/StudyDetails.aspx?study=0813. Accessed Month Day, Year.
7. J. Fowler, W.A. Tomè, and J.D. Fenwick A challenge to traditional radiation oncology Int J Radiat Oncol Biol Phys 60 2004 1241 1256
8. T.R. Mackie, T. Holmes, and S. Swerdloff et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy Med Phys 20 1993 1709 1719
9. A. Bearz, E. Minatel, and I. Abu Rumeileh et al. Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen BMC Cancer 13 2013 513
10. C. Park, L. Papiez, and S. Zhang et al. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
11. E.X. Huang, A.J. Hope, and E. Lindsay et al. Heart irradiation as a risk factor for radiation pneumonitis Acta Oncol 50 2011 51 60
12. S.D. Karam, Z.D. Horne, and R.L. Hong et al. Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer Radiat Oncol 8 2013 179 286
13. P. Kelly, P.A. Balter, and N. Rebueno et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation Int J Radiat Oncol Biol Phys 78 2010 1387 1393
14. N. Trakul, J.P. Harris, and Q.T. Le et al. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors J Thorac Oncol 7 2012 1462 1465
15. K.L. Wu, J.L. Jiang, and H. Quian et al. Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I-II clinical trial Int J Radiat Oncol Biol Phys 57 2003 1345 1350
16. T. Tada, H. Fukuda, and K. Matsui et al. Non-small cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy Int J Clin Oncol 10 2005 247 250